EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction

Jie Wang, Zihang Yuan, Haoran Zhang, Qianhui Tang, Yingying Miao, Anqin Li, Qingyu Chen, Xiaoyan Zhou, Qinwei Yu, Luyong Zhang, Zhenzhou Jiang

Cell Biology and Toxicology · 27.03.2026 · 42 (1)

DOI: 10.1007/s10565-026-10176-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 27.03.2026. Verfasst von Jie Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Screening and Pharmacodynamics Evaluation Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, State Key Laboratory of Natur…. Hauptthemen laut MEDLINE: Macrophages, Chenodeoxycholic Acid, Transcription Factor RelB, Cholestasis. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, "Double First-Class" University project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesChenodeoxycholic AcidTranscription Factor RelBCholestasisChemical and Drug Induced Liver InjuryAnimalsMiceSignal TransductionMaleMice, Inbred C57BLBile DuctsLiver

Stichwörter der Autor:innen

CholestasisDuctular reactionMacrophageNLRP12Obeticholic acidRelb

Substanzen

Chenodeoxycholic Acidobeticholic acidTranscription Factor RelBRelb protein, mouse

Autor:innen und Institutionen

  • New Drug Screening and Pharmacodynamics Evaluation Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.
  • New Drug Screening and Pharmacodynamics Evaluation Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.…
  • Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, 510006, China. lyzhang@cpu.edu.cn.
  • Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, China. beaglejiang@cpu.edu.cn.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • "Double First-Class" University project

Zitieren

APA

Wang, J., Yuan, Z., Zhang, H., Tang, Q., Miao, Y., Li, A., Chen, Q., Zhou, X., Yu, Q., Zhang, L., & Jiang, Z. (2026). Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction. Cell Biology and Toxicology, 42(1). https://doi.org/10.1007/s10565-026-10176-1

Vancouver

Wang J, Yuan Z, Zhang H, Tang Q, Miao Y, Li A, et al. Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction. Cell Biology and Toxicology. 2026;42(1). doi:10.1007/s10565-026-10176-1

BibTeX
@article{Wang2026,
  author = {Wang, Jie and Yuan, Zihang and Zhang, Haoran and Tang, Qianhui and Miao, Yingying and Li, Anqin and Chen, Qingyu and Zhou, Xiaoyan and Yu, Qinwei and Zhang, Luyong and Jiang, Zhenzhou},
  title = {Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  volume = {42},
  number = {1},
  doi = {10.1007/s10565-026-10176-1}
}
Kostenlos starten →